1 | P 140 | - | - | - | - | 1件: 49 49 💬
|
2 | P-1037 | - | - | - | - | 1件: 299 299 💬
|
3 | P-188 NF | - | - | - | - | 1件: 113 113 💬
|
4 | P-552 | - | - | - | - | 1件: 53 53 💬
|
5 | P144 | - | - | - | - | 1件: 51 51 💬
|
6 | P144 cream | - | - | - | - | 1件: 51 51 💬
|
7 | P144 Cytokine Inhibitor | - | - | - | - | 1件: 51 51 💬
|
8 | P144 Cytokines Inhibitors | - | - | - | - | 1件: 51 51 💬
|
9 | P144 DIGNA CREAM | - | - | - | - | 1件: 51 51 💬
|
10 | P144. Cytokines Inhibitors | - | - | - | - | 1件: 51 51 💬
|
11 | P28GST | - | - | - | - | 1件: 96 96 💬
|
12 | P2B001 | - | - | - | - | 1件: 6 6 💬
|
13 | P2B001 once daily (pramipexole 0.3 mg / rasagiline 0.75 mg), | 2件: Pramipexole Pramipexole, Rasagiline | 3件: Pramipexole
Pramipexole
,
Rasagiline
,
Rasagiline tartrate
💬
| 4件: DRD2 DRD2, DRD3, DRD4, MAOB 💬
| 18件: Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Gap junction, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
14 | P2B001 once daily (pramipexole 0.6 mg / rasagiline 0.75 mg), | 2件: Pramipexole Pramipexole, Rasagiline | 3件: Pramipexole
Pramipexole
,
Rasagiline
,
Rasagiline tartrate
💬
| 4件: DRD2 DRD2, DRD3, DRD4, MAOB 💬
| 18件: Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Gap junction, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
15 | P32 | - | - | - | - | 1件: 37 37 💬
|
16 | P32/98 | - | - | - | - | 1件: 37 37 💬
|
17 | P32/98 3% | - | - | - | - | 1件: 37 37 💬
|
18 | P38 (4) Map Kinase Inhibitor | - | - | - | - | 1件: 46 46 💬
|
19 | P38 Inhibitor (4) | - | - | - | - | 1件: 46 46 💬
|
20 | P38 Inhibitor (4) 150mg | - | - | - | - | 1件: 46 46 💬
|
21 | P38 Inhibitor (4) 25mg | - | - | - | - | 1件: 46 46 💬
|
22 | P38 Inhibitor (4) 300mg | - | - | - | - | 1件: 46 46 💬
|
23 | P38 Inhibitor (4) 50mg | - | - | - | - | 1件: 46 46 💬
|
24 | P38 Inhibitor (4) 75mg | - | - | - | - | 1件: 46 46 💬
|
25 | P38 Map Kinase Inhibitor | - | - | - | - | 1件: 46 46 💬
|
26 | P38(4) Map Kinase Inhibitor | - | - | - | - | 1件: 46 46 💬
|
27 | PA101 | - | - | - | - | 1件: 85 85 💬
|
28 | PAAG15 | - | - | - | - | 1件: 299 299 💬
|
29 | Pabinafusp alfa | 1件: Pabinafusp alfa Pabinafusp alfa | 1件: Pabinafusp alfa
Pabinafusp alfa
💬
| 2件: IDS IDS, TFRC 💬
| 8件: Endocytosis Endocytosis, Ferroptosis, Glycosaminoglycan degradation, HIF-1 signaling pathway, Hematopoietic cell lineage, Lysosome, Metabolic pathways, Phagosome 💬 | 1件: 19 19 💬
|
30 | Paclitaxel | 1件: Paclitaxel Paclitaxel | 1件: Paclitaxel
Paclitaxel
💬
| 9件: TUBB TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬
| 10件: Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 💬 | 2件: 46 46, 85 💬
|
31 | Padsevonil | 1件: Padsevonil Padsevonil | 1件: Padsevonil
Padsevonil
💬
| 3件: SV2A SV2A, SV2B, SV2C 💬
| 1件: ECM-receptor interaction ECM-receptor interaction 💬 | 1件: 149 149 💬
|
32 | PAH | - | - | - | - | 3件: 49 49, 53, 86 💬
|
33 | PAH medication | - | - | - | - | 1件: 86 86 💬
|
34 | PAH Therapies | - | - | - | - | 1件: 86 86 💬
|
35 | Palifermin | 1件: Palifermin Palifermin | 1件: Palifermin
Palifermin
💬
| 1件: FGFR2 FGFR2 💬
| 13件: Calcium signaling pathway Calcium signaling pathway, Central carbon metabolism in cancer, EGFR tyrosine kinase inhibitor resistance, Endocytosis, Gastric cancer, MAPK signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Signaling pathways regulating pluripotency of stem cells 💬 | 5件: 13 13, 36, 38, 39, 65 💬
|
36 | Palmitate | 1件: Palmitic Acid Palmitic Acid | 1件: Palmitic acid
Palmitic acid
💬
| - | - | 1件: 63 63 💬
|
37 | Palmitoleic Acid | 1件: Palmitoleic Acid Palmitoleic Acid | - | - | - | 1件: 97 97 💬
|
38 | Palmitoylethanolamide | 1件: Palmidrol Palmidrol | 1件: Palmidrol
Palmidrol
💬
| - | - | 1件: 2 2 💬
|
39 | Palopegteriparatide | - | - | - | - | 1件: 235 235 💬
|
40 | Palopegteriparatide (TransCon PTH) | - | - | - | - | 1件: 235 235 💬
|
41 | PALOVAROTENE | 1件: Palovarotene Palovarotene | 1件: Palovarotene
Palovarotene
💬
| 1件: RARG RARG 💬
| - | 1件: 272 272 💬
|
42 | PALOVAROTENE - 1.5mg | 1件: Palovarotene Palovarotene | 1件: Palovarotene
Palovarotene
💬
| 1件: RARG RARG 💬
| - | 1件: 272 272 💬
|
43 | PALOVAROTENE - 10 mg | 1件: Palovarotene Palovarotene | 1件: Palovarotene
Palovarotene
💬
| 1件: RARG RARG 💬
| - | 1件: 272 272 💬
|
44 | PALOVAROTENE - 1mg | 1件: Palovarotene Palovarotene | 1件: Palovarotene
Palovarotene
💬
| 1件: RARG RARG 💬
| - | 1件: 272 272 💬
|
45 | PALOVAROTENE - 2 mg | 1件: Palovarotene Palovarotene | 1件: Palovarotene
Palovarotene
💬
| 1件: RARG RARG 💬
| - | 1件: 272 272 💬
|
46 | PALOVAROTENE - 2.5 mg | 1件: Palovarotene Palovarotene | 1件: Palovarotene
Palovarotene
💬
| 1件: RARG RARG 💬
| - | 1件: 272 272 💬
|
47 | PALOVAROTENE - 3 mg | 1件: Palovarotene Palovarotene | 1件: Palovarotene
Palovarotene
💬
| 1件: RARG RARG 💬
| - | 1件: 272 272 💬
|
48 | PALOVAROTENE - 4 mg | 1件: Palovarotene Palovarotene | 1件: Palovarotene
Palovarotene
💬
| 1件: RARG RARG 💬
| - | 1件: 272 272 💬
|
49 | PALOVAROTENE - 5 mg | 1件: Palovarotene Palovarotene | 1件: Palovarotene
Palovarotene
💬
| 1件: RARG RARG 💬
| - | 1件: 272 272 💬
|
50 | PALOVAROTENE 1.5 mg | 1件: Palovarotene Palovarotene | 1件: Palovarotene
Palovarotene
💬
| 1件: RARG RARG 💬
| - | 1件: 272 272 💬
|
51 | Palovarotene dose level 1 | 1件: Palovarotene Palovarotene | 1件: Palovarotene
Palovarotene
💬
| 1件: RARG RARG 💬
| - | 1件: 272 272 💬
|
52 | Palovarotene dose level 2 | 1件: Palovarotene Palovarotene | 1件: Palovarotene
Palovarotene
💬
| 1件: RARG RARG 💬
| - | 1件: 272 272 💬
|
53 | Palovarotene dose level 3 | 1件: Palovarotene Palovarotene | 1件: Palovarotene
Palovarotene
💬
| 1件: RARG RARG 💬
| - | 1件: 272 272 💬
|
54 | Palovarotene dose level 4 | 1件: Palovarotene Palovarotene | 1件: Palovarotene
Palovarotene
💬
| 1件: RARG RARG 💬
| - | 1件: 272 272 💬
|
55 | PALOVAROTENE-2 mg | 1件: Palovarotene Palovarotene | 1件: Palovarotene
Palovarotene
💬
| 1件: RARG RARG 💬
| - | 1件: 272 272 💬
|
56 | PALOVAROTENE-3 mg | 1件: Palovarotene Palovarotene | 1件: Palovarotene
Palovarotene
💬
| 1件: RARG RARG 💬
| - | 1件: 272 272 💬
|
57 | PALOVAROTENE-4 mg | 1件: Palovarotene Palovarotene | 1件: Palovarotene
Palovarotene
💬
| 1件: RARG RARG 💬
| - | 1件: 272 272 💬
|
58 | Palynziq | 1件: Pegvaliase Pegvaliase | 1件: Pegvaliase
Pegvaliase
💬
| 1件: PAH PAH 💬
| 5件: Biosynthesis of amino acids Biosynthesis of amino acids, Folate biosynthesis, Metabolic pathways, Phenylalanine metabolism, Phenylalanine, tyrosine and tryptophan biosynthesis 💬 | 1件: 240 240 💬
|
59 | Pamidronate | 1件: Pamidronic acid Pamidronic acid | 1件: Pamidronic acid
Pamidronic acid
💬
| 1件: FDPS FDPS 💬
| 4件: Human T-cell leukemia virus 1 infection Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | 3件: 270 270, 271, 274 💬
|
60 | Pamidronate (Aredia) | 1件: Pamidronic acid Pamidronic acid | 1件: Pamidronic acid
Pamidronic acid
💬
| 1件: FDPS FDPS 💬
| 4件: Human T-cell leukemia virus 1 infection Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | 1件: 274 274 💬
|
61 | PAMREVLUMAB | 1件: Pamrevlumab Pamrevlumab | 1件: Pamrevlumab
Pamrevlumab
💬
| 1件: CCN2 CCN2 💬
| 2件: Apelin signaling pathway Apelin signaling pathway, Hippo signaling pathway 💬 | 2件: 85 85, 113 💬
|
62 | Pamrevlumab (FG-3019) | 1件: Pamrevlumab Pamrevlumab | 1件: Pamrevlumab
Pamrevlumab
💬
| 1件: CCN2 CCN2 💬
| 2件: Apelin signaling pathway Apelin signaling pathway, Hippo signaling pathway 💬 | 1件: 113 113 💬
|
63 | Panax Quinquefolius | 1件: Panax quinquefolius whole Panax quinquefolius whole | - | - | - | 1件: 46 46 💬
|
64 | Pancreas Powder | - | - | - | - | 1件: 299 299 💬
|
65 | Pancrease | - | - | - | - | 1件: 299 299 💬
|
66 | PANCREASE MT | - | - | - | - | 1件: 299 299 💬
|
67 | Pancrease MT 10.5, or MT 21 | - | - | - | - | 1件: 299 299 💬
|
68 | PANCREASLIPASE | - | - | - | - | 1件: 299 299 💬
|
69 | Pancreatic enzyme(Pancreatin Enteric-coated Capsules or Oryz-Aspergillus Enzyme and Pancreatin Table), antidiabetic medicine(Acarbose Tablets, Glucophage, Glimepirde Tablets) | 2件: Acarbose Acarbose, Pancrelipase | 2件: Acarbose
Acarbose
,
Pancrelipase
💬
| 5件: AMY2A AMY2A, AMY2B, GAA, GANC, MGAM 💬
| 7件: Carbohydrate digestion and absorption Carbohydrate digestion and absorption, Galactose metabolism, Lysosome, Metabolic pathways, Pancreatic secretion, Salivary secretion, Starch and sucrose metabolism 💬 | 1件: 298 298 💬
|
70 | Pancreatic enzymes | - | - | - | - | 1件: 298 298 💬
|
71 | Pancreatin | 1件: Pancrelipase Pancrelipase | 1件: Pancrelipase
Pancrelipase
💬
| - | - | 2件: 298 298, 299 💬
|
72 | PANCREATIN (PAncreas Powder) | 1件: Pancrelipase Pancrelipase | 1件: Pancrelipase
Pancrelipase
💬
| - | - | 1件: 299 299 💬
|
73 | PANCREATINA | - | - | - | - | 1件: 299 299 💬
|
74 | PANCREATINA (Páncreas Polvo | - | - | - | - | 1件: 299 299 💬
|
75 | PANCREATINA (Páncreas Polvo) | - | - | - | - | 1件: 299 299 💬
|
76 | PANCREAZE | - | - | - | - | 1件: 299 299 💬
|
77 | PANCREAZE® | - | - | - | - | 1件: 299 299 💬
|
78 | PANCRECARB® (pancrelipase) | 1件: Pancrelipase Pancrelipase | 1件: Pancrelipase
Pancrelipase
💬
| - | - | 1件: 299 299 💬
|
79 | Pancrelipase | 2件: Pancrelipase Pancrelipase, Pancrelipase amylase | 1件: Pancrelipase
Pancrelipase
💬
| - | - | 2件: 298 298, 299 💬
|
80 | PANCRELIPASE AMYLASE | 2件: Pancrelipase Pancrelipase, Pancrelipase amylase | 1件: Pancrelipase
Pancrelipase
💬
| - | - | 1件: 299 299 💬
|
81 | Pancrelipase Delayed Release | 1件: Pancrelipase Pancrelipase | 1件: Pancrelipase
Pancrelipase
💬
| - | - | 1件: 299 299 💬
|
82 | Pancrelipase Delayed Release Capsule | 1件: Pancrelipase Pancrelipase | 1件: Pancrelipase
Pancrelipase
💬
| - | - | 2件: 298 298, 299 💬
|
83 | Pancrelipase Microtablets | 1件: Pancrelipase Pancrelipase | 1件: Pancrelipase
Pancrelipase
💬
| - | - | 1件: 299 299 💬
|
84 | Pancrelipase with bicarbonate | 1件: Pancrelipase Pancrelipase | 1件: Pancrelipase
Pancrelipase
💬
| - | - | 1件: 299 299 💬
|
85 | Pancrelipase/Pancreas Powder | 1件: Pancrelipase Pancrelipase | 1件: Pancrelipase
Pancrelipase
💬
| - | - | 2件: 298 298, 299 💬
|
86 | Pandemrix, | - | - | - | - | 1件: 46 46 💬
|
87 | Panhematin | 1件: Hemin Hemin | 1件: Hemin
Hemin
💬
| 2件: ALAS1 ALAS1, ALAS2 💬
| 4件: Biosynthesis of cofactors Biosynthesis of cofactors, Glycine, serine and threonine metabolism, Metabolic pathways, Porphyrin metabolism 💬 | 1件: 254 254 💬
|
88 | Pankreatin | - | - | - | - | 1件: 299 299 💬
|
89 | Pantethine | 1件: Pantethine Pantethine | 1件: Pantethine
Pantethine
💬
| - | - | 1件: 120 120 💬
|
90 | Pantoprazole | 1件: Pantoprazole Pantoprazole | 1件: Pantoprazole
Pantoprazole
💬
| 2件: ATP4A ATP4A, ATP4B 💬
| 4件: Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬 | 2件: 13 13, 65 💬
|
91 | Pantoprazolo 20 mg gastro-resistant tablets | - | - | - | - | 1件: 65 65 💬
|
92 | PANZYGA | - | - | - | - | 1件: 14 14 💬
|
93 | Panzytrat | - | - | - | - | 1件: 298 298 💬
|
94 | Panzytrat 25.000 | - | - | - | - | 1件: 298 298 💬
|
95 | Panzytrat 25.000 FIP-E units of Lipase | - | - | - | - | 1件: 298 298 💬
|
96 | PANZYTRAT 25000 | - | - | - | - | 1件: 299 299 💬
|
97 | Panzytrat® 25,000 | - | - | - | - | 1件: 299 299 💬
|
98 | Panzytrat® ok | - | - | - | - | 1件: 299 299 💬
|
99 | Paquinimod | 1件: Paquinimod Paquinimod | - | - | - | 2件: 49 49, 51 💬
|
100 | Paquinimod (ABR-215757) | 1件: Paquinimod Paquinimod | - | - | - | 1件: 49 49 💬
|
101 | PARACETAMOL | 1件: Acetaminophen Acetaminophen | 1件: Acetaminophen
Acetaminophen
💬
| 2件: PTGS1 PTGS1, PTGS2 💬
| 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 6件: 3 3, 6, 13, 35, 46, 49 💬
|
102 | Paracetamol (acetaminophen) | 1件: Acetaminophen Acetaminophen | 1件: Acetaminophen
Acetaminophen
💬
| 2件: PTGS1 PTGS1, PTGS2 💬
| 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 46 46 💬
|
103 | Paracetamol 120Mg/5mL Oral Suspension | 1件: Acetaminophen Acetaminophen | 1件: Acetaminophen
Acetaminophen
💬
| 2件: PTGS1 PTGS1, PTGS2 💬
| 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 3 3 💬
|
104 | PARACETAMOLO | - | - | - | - | 9件: 2 2, 11, 14, 19, 28, 53, 61, 63, 300 💬
|
105 | Paracetamolo 500 mg | - | - | - | - | 1件: 13 13 💬
|
106 | PARACETAMOLO DC.IT FU | - | - | - | - | 1件: 46 46 💬
|
107 | PARACETAMOLO DOC GENERICI - 1000 MG COMPRESSA 16 COMPRESSE | - | - | - | - | 1件: 19 19 💬
|
108 | PARACETAMOLO NOVA ARGENTIA - 500 MG COMPRESSE 20 COMPRESSE | - | - | - | - | 1件: 300 300 💬
|
109 | Paracetamolo Zentiva Italia | - | - | - | - | 1件: 28 28 💬
|
110 | Paraclisib | - | - | - | - | 1件: 61 61 💬
|
111 | Paraffin Oil | 1件: Mineral oil Mineral oil | 1件: Mineral oil
Mineral oil
💬
| - | - | 1件: 291 291 💬
|
112 | PARALEN 500 | - | - | - | - | 1件: 46 46 💬
|
113 | Parapres | - | - | - | - | 1件: 6 6 💬
|
114 | Parathyroid hormon 1-84 | - | - | - | - | 1件: 235 235 💬
|
115 | Parathyroid hormone | 1件: Parathyroid hormone Parathyroid hormone | 1件: Parathyroid hormone
Parathyroid hormone
💬
| 2件: PTH1R PTH1R, PTH2R 💬
| 3件: Endocrine and other factor-regulated calcium reabsorption Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬 | 2件: 70 70, 235 💬
|
116 | Parathyroid Hormone (1-84) Human Recombinant | 1件: Parathyroid hormone Parathyroid hormone | 1件: Parathyroid hormone
Parathyroid hormone
💬
| 2件: PTH1R PTH1R, PTH2R 💬
| 3件: Endocrine and other factor-regulated calcium reabsorption Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬 | 1件: 235 235 💬
|
117 | Parathyroid Hormone (rDNA) | 1件: Parathyroid hormone Parathyroid hormone | 1件: Parathyroid hormone
Parathyroid hormone
💬
| 2件: PTH1R PTH1R, PTH2R 💬
| 3件: Endocrine and other factor-regulated calcium reabsorption Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬 | 1件: 235 235 💬
|
118 | Parathyroideahormon | - | - | - | - | 1件: 235 235 💬
|
119 | PARCOPA | 2件: Carbidopa Carbidopa, Levodopa | 2件: Levodopa
Levodopa
,
Carbidopa
💬
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 16件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
120 | Pardaprunox | - | - | - | - | 1件: 6 6 💬
|
121 | Pardoprunox | 1件: Pardoprunox Pardoprunox | 1件: Pardoprunox
Pardoprunox
💬
| 3件: DRD2 DRD2, DRD3, HTR1A 💬
| 10件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, Taste transduction, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
122 | Pardoprunox hydrochloride | 1件: Pardoprunox Pardoprunox | 1件: Pardoprunox
Pardoprunox
💬
| 3件: DRD2 DRD2, DRD3, HTR1A 💬
| 10件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, Taste transduction, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
123 | Parecoxib | 1件: Parecoxib Parecoxib | 1件: Parecoxib
Parecoxib
💬
| 1件: PTGS2 PTGS2 💬
| 22件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 2件: 46 46, 271 💬
|
124 | Parenteral Remodulin (treprostinil) injection | 1件: Treprostinil Treprostinil | 1件: Treprostinil
Treprostinil
💬
| 1件: PTGIR PTGIR 💬
| 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | 1件: 86 86 💬
|
125 | Parenteral Treprostinil | 1件: Treprostinil Treprostinil | 1件: Treprostinil
Treprostinil
💬
| 1件: PTGIR PTGIR 💬
| 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | 1件: 86 86 💬
|
126 | Paricalcitol | 1件: Paricalcitol Paricalcitol | 1件: Paricalcitol
Paricalcitol
💬
| 1件: VDR VDR 💬
| 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 5件: 19 19, 66, 218, 238, 298 💬
|
127 | Parnaparin | 1件: Parnaparin Parnaparin | 1件: Adomiparin
Adomiparin
💬
| 1件: SERPINC1 SERPINC1 💬
| 1件: Complement and coagulation cascades Complement and coagulation cascades 💬 | 1件: 97 97 💬
|
128 | PARNAPARIN SODIUM | 1件: Parnaparin Parnaparin | 1件: Adomiparin
Adomiparin
💬
| 1件: SERPINC1 SERPINC1 💬
| 1件: Complement and coagulation cascades Complement and coagulation cascades 💬 | 1件: 97 97 💬
|
129 | Paroxetine | 1件: Paroxetine Paroxetine | 1件: Paroxetine
Paroxetine
💬
| 1件: SLC6A4 SLC6A4 💬
| 2件: Serotonergic synapse Serotonergic synapse, Synaptic vesicle cycle 💬 | 4件: 6 6, 13, 46, 85 💬
|
130 | Paroxetine & Prednisolone | 2件: Paroxetine Paroxetine, Prednisolone | 2件: Prednisolone
Prednisolone
,
Paroxetine
💬
| 2件: NR3C1 NR3C1, SLC6A4 💬
| 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 💬 | 1件: 46 46 💬
|
131 | Paroxetine hydrochloride 10 & 20 mg and Prednisolone 1 mg BP | 2件: Paroxetine Paroxetine, Prednisolone | 2件: Prednisolone
Prednisolone
,
Paroxetine
💬
| 2件: NR3C1 NR3C1, SLC6A4 💬
| 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 💬 | 1件: 46 46 💬
|
132 | Paroxetine Hydrochloride tablets 10 & 20 mg and Prednisolone 1 mg BP | 2件: Paroxetine Paroxetine, Prednisolone | 2件: Prednisolone
Prednisolone
,
Paroxetine
💬
| 2件: NR3C1 NR3C1, SLC6A4 💬
| 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 💬 | 1件: 46 46 💬
|
133 | Parsaclisib | 1件: Parsaclisib Parsaclisib | 1件: Parsaclisib
Parsaclisib
💬
| 1件: PIK3CD PIK3CD 💬
| 106件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, AMPK signaling pathway, Acute myeloid leukemia, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Amoebiasis, Apoptosis, Autophagy - animal, Axon guidance, B cell receptor signaling pathway, Bacterial invasion of epithelial cells, Breast cancer, C-type lectin receptor signaling pathway, Carbohydrate digestion and absorption, Cellular senescence, Central carbon metabolism in cancer, Chagas disease, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, Epstein-Barr virus infection, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gastric cancer, Glioma, GnRH secretion, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory mediator regulation of TRP channels, Influenza A, Inositol phosphate metabolism, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, Longevity regulating pathway, Longevity regulating pathway - multiple species, Measles, Melanoma, Metabolic pathways, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Phosphatidylinositol signaling system, Phospholipase D signaling pathway, Platelet activation, Platinum drug resistance, Prion disease, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Regulation of lipolysis in adipocytes, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Small cell lung cancer, Sphingolipid signaling pathway, Spinocerebellar ataxia, T cell receptor signaling pathway, TNF signaling pathway, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, Type II diabetes mellitus, VEGF signaling pathway, Viral carcinogenesis, Yersinia infection, cAMP signaling pathway, mTOR signaling pathway 💬 | 3件: 35 35, 53, 61 💬
|
134 | Parsaclisib (1 mg) | 1件: Parsaclisib Parsaclisib | 1件: Parsaclisib
Parsaclisib
💬
| 1件: PIK3CD PIK3CD 💬
| 106件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, AMPK signaling pathway, Acute myeloid leukemia, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Amoebiasis, Apoptosis, Autophagy - animal, Axon guidance, B cell receptor signaling pathway, Bacterial invasion of epithelial cells, Breast cancer, C-type lectin receptor signaling pathway, Carbohydrate digestion and absorption, Cellular senescence, Central carbon metabolism in cancer, Chagas disease, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, Epstein-Barr virus infection, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gastric cancer, Glioma, GnRH secretion, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory mediator regulation of TRP channels, Influenza A, Inositol phosphate metabolism, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, Longevity regulating pathway, Longevity regulating pathway - multiple species, Measles, Melanoma, Metabolic pathways, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Phosphatidylinositol signaling system, Phospholipase D signaling pathway, Platelet activation, Platinum drug resistance, Prion disease, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Regulation of lipolysis in adipocytes, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Small cell lung cancer, Sphingolipid signaling pathway, Spinocerebellar ataxia, T cell receptor signaling pathway, TNF signaling pathway, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, Type II diabetes mellitus, VEGF signaling pathway, Viral carcinogenesis, Yersinia infection, cAMP signaling pathway, mTOR signaling pathway 💬 | 1件: 61 61 💬
|
135 | Parsaclisib (2.5 mg) | 1件: Parsaclisib Parsaclisib | 1件: Parsaclisib
Parsaclisib
💬
| 1件: PIK3CD PIK3CD 💬
| 106件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, AMPK signaling pathway, Acute myeloid leukemia, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Amoebiasis, Apoptosis, Autophagy - animal, Axon guidance, B cell receptor signaling pathway, Bacterial invasion of epithelial cells, Breast cancer, C-type lectin receptor signaling pathway, Carbohydrate digestion and absorption, Cellular senescence, Central carbon metabolism in cancer, Chagas disease, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, Epstein-Barr virus infection, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gastric cancer, Glioma, GnRH secretion, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory mediator regulation of TRP channels, Influenza A, Inositol phosphate metabolism, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, Longevity regulating pathway, Longevity regulating pathway - multiple species, Measles, Melanoma, Metabolic pathways, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Phosphatidylinositol signaling system, Phospholipase D signaling pathway, Platelet activation, Platinum drug resistance, Prion disease, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Regulation of lipolysis in adipocytes, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Small cell lung cancer, Sphingolipid signaling pathway, Spinocerebellar ataxia, T cell receptor signaling pathway, TNF signaling pathway, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, Type II diabetes mellitus, VEGF signaling pathway, Viral carcinogenesis, Yersinia infection, cAMP signaling pathway, mTOR signaling pathway 💬 | 1件: 61 61 💬
|
136 | Parsaclisinib | - | - | - | - | 1件: 61 61 💬
|
137 | Part 1 Levulan injection | - | - | - | - | 1件: 34 34 💬
|
138 | Part 1 Levulan surface application | - | - | - | - | 1件: 34 34 💬
|
139 | Part 1 Levulan surface application twice | - | - | - | - | 1件: 34 34 💬
|
140 | Part 1 Levulan surface application twice with microneedling | - | - | - | - | 1件: 34 34 💬
|
141 | Part 1, JM-010 component Group A | - | - | - | - | 1件: 6 6 💬
|
142 | Part 1, JM-010 component Group B | - | - | - | - | 1件: 6 6 💬
|
143 | Part 1, JM-010 component Group C | - | - | - | - | 1件: 6 6 💬
|
144 | Part 1: LJN452 | - | - | - | - | 1件: 93 93 💬
|
145 | Part 2 Adult Alogabat High Dose (aged 15-17) | - | - | - | - | 1件: 201 201 💬
|
146 | Part 2, JM-010 combination Group A | - | - | - | - | 1件: 6 6 💬
|
147 | Part 2, JM-010 combination Group B | - | - | - | - | 1件: 6 6 💬
|
148 | Part 2, JM-010 component Group C | - | - | - | - | 1件: 6 6 💬
|
149 | Part 2: LJN452 Dose level 1 | - | - | - | - | 1件: 93 93 💬
|
150 | Part 2: LJN452 Dose level 2 | - | - | - | - | 1件: 93 93 💬
|
151 | Part A | - | - | - | - | 1件: 46 46 💬
|
152 | Part A: 100 mg/mL GSK2618960 | - | - | - | - | 1件: 13 13 💬
|
153 | Part B | - | - | - | - | 1件: 46 46 💬
|
154 | Part B Open-Label Extension | - | - | - | - | 1件: 51 51 💬
|
155 | Part B: Dose of GSK2618960 decided from Part A | - | - | - | - | 1件: 13 13 💬
|
156 | Part C: Dose of GSK2618960 decided from Part A and B | - | - | - | - | 1件: 13 13 💬
|
157 | Part I - etoricoxib 60 mg | 1件: Etoricoxib Etoricoxib | 1件: Etoricoxib
Etoricoxib
💬
| 1件: PTGS2 PTGS2 💬
| 22件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 271 271 💬
|
158 | Part I - etoricoxib 90 mg | 1件: Etoricoxib Etoricoxib | 1件: Etoricoxib
Etoricoxib
💬
| 1件: PTGS2 PTGS2 💬
| 22件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 271 271 💬
|
159 | Part I- naproxen 1000 mg | 1件: Naproxen Naproxen | 1件: Naproxen
Naproxen
💬
| 2件: PTGS1 PTGS1, PTGS2 💬
| 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 271 271 💬
|
160 | Part II- etoricoxib 60 mg | 1件: Etoricoxib Etoricoxib | 1件: Etoricoxib
Etoricoxib
💬
| 1件: PTGS2 PTGS2 💬
| 22件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 271 271 💬
|
161 | Part II- etoricoxib 90 mg | 1件: Etoricoxib Etoricoxib | 1件: Etoricoxib
Etoricoxib
💬
| 1件: PTGS2 PTGS2 💬
| 22件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 271 271 💬
|
162 | Part II- naproxen 1000 mg | 1件: Naproxen Naproxen | 1件: Naproxen
Naproxen
💬
| 2件: PTGS1 PTGS1, PTGS2 💬
| 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 271 271 💬
|
163 | Partial Enteral Nutrition | - | - | - | - | 1件: 96 96 💬
|
164 | Pasireotida | 1件: Pasireotide Pasireotide | 1件: Pasireotide
Pasireotide
💬
| 4件: SSTR1 SSTR1, SSTR2, SSTR3, SSTR5 💬
| 4件: Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 75 75 💬
|
165 | Pasireotida 300 | 1件: Pasireotide Pasireotide | 1件: Pasireotide
Pasireotide
💬
| 4件: SSTR1 SSTR1, SSTR2, SSTR3, SSTR5 💬
| 4件: Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 75 75 💬
|
166 | Pasireotida 600 | 1件: Pasireotide Pasireotide | 1件: Pasireotide
Pasireotide
💬
| 4件: SSTR1 SSTR1, SSTR2, SSTR3, SSTR5 💬
| 4件: Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 75 75 💬
|
167 | Pasireotida 900 | 1件: Pasireotide Pasireotide | 1件: Pasireotide
Pasireotide
💬
| 4件: SSTR1 SSTR1, SSTR2, SSTR3, SSTR5 💬
| 4件: Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 75 75 💬
|
168 | Pasireotide | 1件: Pasireotide Pasireotide | 1件: Pasireotide
Pasireotide
💬
| 4件: SSTR1 SSTR1, SSTR2, SSTR3, SSTR5 💬
| 4件: Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 3件: 67 67, 74, 75 💬
|
169 | Pasireotide 0.3mg | 1件: Pasireotide Pasireotide | 1件: Pasireotide
Pasireotide
💬
| 4件: SSTR1 SSTR1, SSTR2, SSTR3, SSTR5 💬
| 4件: Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 75 75 💬
|
170 | Pasireotide 0.6 MG/ML | 1件: Pasireotide Pasireotide | 1件: Pasireotide
Pasireotide
💬
| 4件: SSTR1 SSTR1, SSTR2, SSTR3, SSTR5 💬
| 4件: Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 75 75 💬
|
171 | Pasireotide 0.6mg | 1件: Pasireotide Pasireotide | 1件: Pasireotide
Pasireotide
💬
| 4件: SSTR1 SSTR1, SSTR2, SSTR3, SSTR5 💬
| 4件: Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 75 75 💬
|
172 | Pasireotide 0.9 mg | 1件: Pasireotide Pasireotide | 1件: Pasireotide
Pasireotide
💬
| 4件: SSTR1 SSTR1, SSTR2, SSTR3, SSTR5 💬
| 4件: Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 75 75 💬
|
173 | Pasireotide 20mg | 1件: Pasireotide Pasireotide | 1件: Pasireotide
Pasireotide
💬
| 4件: SSTR1 SSTR1, SSTR2, SSTR3, SSTR5 💬
| 4件: Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 75 75 💬
|
174 | Pasireotide 40mg | 1件: Pasireotide Pasireotide | 1件: Pasireotide
Pasireotide
💬
| 4件: SSTR1 SSTR1, SSTR2, SSTR3, SSTR5 💬
| 4件: Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 75 75 💬
|
175 | Pasireotide 60mg | 1件: Pasireotide Pasireotide | 1件: Pasireotide
Pasireotide
💬
| 4件: SSTR1 SSTR1, SSTR2, SSTR3, SSTR5 💬
| 4件: Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 75 75 💬
|
176 | PASIREOTIDE DIASPARTATE | 1件: Pasireotide Pasireotide | 1件: Pasireotide
Pasireotide
💬
| 4件: SSTR1 SSTR1, SSTR2, SSTR3, SSTR5 💬
| 4件: Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 75 75 💬
|
177 | Pasireotide LAR | 1件: Pasireotide Pasireotide | 1件: Pasireotide
Pasireotide
💬
| 4件: SSTR1 SSTR1, SSTR2, SSTR3, SSTR5 💬
| 4件: Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 2件: 67 67, 75 💬
|
178 | PASIREOTIDE PAMOATE | 1件: Pasireotide Pasireotide | 1件: Pasireotide
Pasireotide
💬
| 4件: SSTR1 SSTR1, SSTR2, SSTR3, SSTR5 💬
| 4件: Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 75 75 💬
|
179 | Pasireotide s.c. | 1件: Pasireotide Pasireotide | 1件: Pasireotide
Pasireotide
💬
| 4件: SSTR1 SSTR1, SSTR2, SSTR3, SSTR5 💬
| 4件: Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 75 75 💬
|
180 | Pasireotide sub-cutaneous | 1件: Pasireotide Pasireotide | 1件: Pasireotide
Pasireotide
💬
| 4件: SSTR1 SSTR1, SSTR2, SSTR3, SSTR5 💬
| 4件: Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 75 75 💬
|
181 | Pasireotide with or without cabergoline | 2件: Cabergoline Cabergoline, Pasireotide | 2件: Cabergoline
Cabergoline
,
Pasireotide
💬
| 6件: DRD2 DRD2, PRL, SSTR1, SSTR2, SSTR3, SSTR5 💬
| 14件: Alcoholism Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, Gastric acid secretion, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 75 75 💬
|
182 | Pasireotode | - | - | - | - | 1件: 75 75 💬
|
183 | PAT | - | - | - | - | 1件: 160 160 💬
|
184 | PAT-001, 0.1% | - | - | - | - | 1件: 160 160 💬
|
185 | PAT-001, 0.2% | - | - | - | - | 1件: 160 160 💬
|
186 | Patient Current Care | - | - | - | - | 1件: 46 46 💬
|
187 | Patient treated with DMARD | - | - | - | - | 1件: 46 46 💬
|
188 | Patients will be randomized to receive EHP-101 | - | - | - | - | 1件: 51 51 💬
|
189 | Patients' existing non-steroidal anti-inflammatory drug (NSAID) at approved doses | - | - | - | - | 1件: 46 46 💬
|
190 | Pazopanib | 1件: Pazopanib Pazopanib | - | - | - | 1件: 227 227 💬
|
191 | PB | - | - | - | - | 2件: 67 67, 225 💬
|
192 | PB006 | - | - | - | - | 1件: 13 13 💬
|
193 | PB1046 | - | - | - | - | 1件: 86 86 💬
|
194 | PB1046 Injection | - | - | - | - | 1件: 113 113 💬
|
195 | PB1046 Subcutaneous Injection | - | - | - | - | 1件: 86 86 💬
|
196 | PB1046, VIP-ELP1-120, Vasomera | - | - | - | - | 1件: 86 86 💬
|
197 | PBA | - | - | - | - | 1件: 231 231 💬
|
198 | PBF-509 | - | - | - | - | 1件: 6 6 💬
|
199 | PBF-677 | - | - | - | - | 1件: 97 97 💬
|
200 | PBF-999 | - | - | - | - | 1件: 8 8 💬
|
201 | PBF-999 / 160 mg | - | - | - | - | 1件: 8 8 💬
|
202 | PBF-999 / 320 mg | - | - | - | - | 1件: 8 8 💬
|
203 | PBFT02 | - | - | - | - | 1件: 127 127 💬
|
204 | PBGM01 | - | - | - | - | 1件: 19 19 💬
|
205 | PBI4050 | - | - | - | - | 2件: 85 85, 299 💬
|
206 | PBKR03 | - | - | - | - | 1件: 19 19 💬
|
207 | PBMC autotransplantation | - | - | - | - | 1件: 2 2 💬
|
208 | PBT2 | - | - | - | - | 1件: 8 8 💬
|
209 | PC945 | - | - | - | - | 1件: 299 299 💬
|
210 | PCA | - | - | - | - | 1件: 70 70 💬
|
211 | PCCLchimGp91s lentiviral vector transduced CD34+ cells infusion | - | - | - | - | 1件: 65 65 💬
|
212 | PCO371 | - | - | - | - | 1件: 235 235 💬
|
213 | PCR polymorphism | - | - | - | - | 1件: 46 46 💬
|
214 | PCT (PureCell Technologies Complex) | - | - | - | - | 1件: 97 97 💬
|
215 | PCV | - | - | - | - | 1件: 13 13 💬
|
216 | PD 0299685 | - | - | - | - | 1件: 226 226 💬
|
217 | PD 0299685 at 15mg BID | - | - | - | - | 1件: 226 226 💬
|
218 | PD 0299685 at 30mg BID | - | - | - | - | 1件: 226 226 💬
|
219 | PD 0360324 | - | - | - | - | 2件: 46 46, 84 💬
|
220 | PD patients H&Y=1.5-2 Medications OFF | - | - | - | - | 1件: 6 6 💬
|
221 | PD patients H&Y=1.5-2 Medications ON | - | - | - | - | 1件: 6 6 💬
|
222 | PD patients H&Y=3 Medications OFF | - | - | - | - | 1件: 6 6 💬
|
223 | PD patients H&Y=3 Medications ON | - | - | - | - | 1件: 6 6 💬
|
224 | PD vitamin supplementation | - | - | - | - | 1件: 6 6 💬
|
225 | PD-0299685 | 1件: PD-0299685 PD-0299685 | - | - | - | 1件: 226 226 💬
|
226 | PD-0325901 | 1件: Mirdametinib Mirdametinib | 1件: Mirdametinib
Mirdametinib
💬
| 2件: MAP2K1 MAP2K1, MAP2K2 💬
| 89件: Acute myeloid leukemia Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, B cell receptor signaling pathway, Bladder cancer, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, Insulin signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, VEGF signaling pathway, Vascular smooth muscle contraction, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway 💬 | 1件: 34 34 💬
|
227 | PD00377 Na-salt | - | - | - | - | 1件: 85 85 💬
|
228 | PDA001 | - | - | - | - | 2件: 46 46, 96 💬
|
229 | PDA001 (cenplacel-L) | - | - | - | - | 1件: 84 84 💬
|
230 | PDE5 inhibitor | - | - | - | - | 1件: 86 86 💬
|
231 | PEA-LUT | - | - | - | - | 1件: 127 127 💬
|
232 | Pectin | 1件: Pectin Pectin | 1件: Pectin
Pectin
💬
| - | - | 1件: 96 96 💬
|
233 | Pednisone | - | - | - | - | 2件: 43 43, 44 💬
|
234 | Peficitinib | 1件: Peficitinib Peficitinib | 1件: Peficitinib
Peficitinib
💬
| 3件: JAK1 JAK1, JAK2, JAK3 💬
| 37件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | 1件: 46 46 💬
|
235 | PEG | - | - | - | - | 15件: 6 6, 13, 41, 46, 60, 65, 78, 96, 97, 140, 144, 240, 246, 299, 337 💬
|
236 | Peg-Ada | - | - | - | - | 1件: 65 65 💬
|
237 | Peg-Interferon alpha-2b | 1件: Interferon alfa-2b Interferon alfa-2b | 1件: Interferon alfa-2b
Interferon alfa-2b
💬
| 2件: IFNAR1 IFNAR1, IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 34 34 💬
|
238 | PEG-interleukin-2 | 1件: Human interleukin-2 Human interleukin-2 | - | - | - | 1件: 65 65 💬
|
239 | PEG-liposomal Prednisolone Sodium Phosphate | 2件: Phosphate ion Phosphate ion, Prednisolone | 1件: Prednisolone
Prednisolone
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 2件: 13 13, 97 💬
|
240 | PEG-rhG-CSF | - | - | - | - | 1件: 60 60 💬
|
241 | PEG-somatropin | 1件: Somatotropin Somatotropin | - | - | - | 1件: 78 78 💬
|
242 | Pegcetacoplam | - | - | - | - | 1件: 2 2 💬
|
243 | PEGCETACOPLAN | 1件: Pegcetacoplan Pegcetacoplan | 1件: Pegcetacoplan
Pegcetacoplan
💬
| 1件: C3 C3 💬
| 17件: Alcoholic liver disease Alcoholic liver disease, Chagas disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Phagosome, Shigellosis, Staphylococcus aureus infection, Systemic lupus erythematosus, Tuberculosis, Viral carcinogenesis 💬 | 4件: 2 2, 61, 62, 222 💬
|
244 | Pegcetacoplan (APL-2) | 1件: Pegcetacoplan Pegcetacoplan | 1件: Pegcetacoplan
Pegcetacoplan
💬
| 1件: C3 C3 💬
| 17件: Alcoholic liver disease Alcoholic liver disease, Chagas disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Phagosome, Shigellosis, Staphylococcus aureus infection, Systemic lupus erythematosus, Tuberculosis, Viral carcinogenesis 💬 | 3件: 2 2, 61, 62 💬
|
245 | Pegfilgrastim | 1件: Pegfilgrastim Pegfilgrastim | 1件: Pegfilgrastim
Pegfilgrastim
💬
| 1件: CSF3R CSF3R 💬
| 5件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | 1件: 60 60 💬
|
246 | Peginesatide | 1件: Peginesatide Peginesatide | 1件: Peginesatide
Peginesatide
💬
| 1件: EPOR EPOR 💬
| 5件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | 1件: 283 283 💬
|
247 | PEGINTERFERON BETA-1A | 1件: Peginterferon beta-1a Peginterferon beta-1a | 1件: Peginterferon beta-1a
Peginterferon beta-1a
💬
| 2件: IFNAR1 IFNAR1, IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 💬
|
248 | Peginterferone beta 1a | - | - | - | - | 1件: 13 13 💬
|
249 | PEGINTERFERONE BETA-1A | - | - | - | - | 1件: 13 13 💬
|
250 | PEGINTERFERONE LAMBDA-1A | - | - | - | - | 1件: 13 13 💬
|
251 | Pegsunercept | 1件: Pegsunercept Pegsunercept | 1件: Pegsunercept
Pegsunercept
💬
| 1件: TNF TNF 💬
| 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 💬
|
252 | Pegsunercept (PEG sTNF-RI) | 1件: Pegsunercept Pegsunercept | 1件: Pegsunercept
Pegsunercept
💬
| 1件: TNF TNF 💬
| 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 💬
|
253 | Pegtarviliase | - | - | - | - | 1件: 337 337 💬
|
254 | Pegtibatinase | - | - | - | - | 1件: 337 337 💬
|
255 | PEGUNIGALSIDASE ALFA | 1件: Pegunigalsidase alfa Pegunigalsidase alfa | 1件: Pegunigalsidase alfa
Pegunigalsidase alfa
💬
| - | - | 1件: 19 19 💬
|
256 | Pegunigalsidase alpha | - | - | - | - | 1件: 19 19 💬
|
257 | PEGVALIASE | 1件: Pegvaliase Pegvaliase | 1件: Pegvaliase
Pegvaliase
💬
| 1件: PAH PAH 💬
| 5件: Biosynthesis of amino acids Biosynthesis of amino acids, Folate biosynthesis, Metabolic pathways, Phenylalanine metabolism, Phenylalanine, tyrosine and tryptophan biosynthesis 💬 | 1件: 240 240 💬
|
258 | Pegvaliase-Pqpz | 1件: Pegvaliase Pegvaliase | 1件: Pegvaliase
Pegvaliase
💬
| 1件: PAH PAH 💬
| 5件: Biosynthesis of amino acids Biosynthesis of amino acids, Folate biosynthesis, Metabolic pathways, Phenylalanine metabolism, Phenylalanine, tyrosine and tryptophan biosynthesis 💬 | 1件: 240 240 💬
|
259 | Pegvisomant | 1件: Pegvisomant Pegvisomant | 1件: Pegvisomant
Pegvisomant
💬
| 1件: GHR GHR 💬
| 5件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | 2件: 78 78, 265 💬
|
260 | PEGylated Intereron Beta-1a | - | - | - | - | 1件: 13 13 💬
|
261 | Pegylated interferon alfa | 1件: Interferon alfa Interferon alfa | 1件: Interferon alfa
Interferon alfa
💬
| 2件: IFNAR1 IFNAR1, IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 96 96 💬
|
262 | Pegylated Interferon Alpha2b | - | - | - | - | 1件: 227 227 💬
|
263 | PEGylated Interferon Beta-1a | 2件: Human interferon beta Human interferon beta, Interferon beta-1a | 1件: Interferon beta-1a
Interferon beta-1a
💬
| 2件: IFNAR1 IFNAR1, IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 💬
|
264 | Pegylated polypeptide hormone of human recombinant origin PEG-hGH | - | - | - | - | 1件: 78 78 💬
|
265 | Pegylated recombinant human growth hormone | 1件: Somatotropin Somatotropin | - | - | - | 1件: 78 78 💬
|
266 | PEGYLATED RECOMBINANT HUMAN HYALURONIDASE PH20 | 2件: Hyaluronidase Hyaluronidase, Hyaluronidase (human recombinant) | 3件: Hyaluronidase
Hyaluronidase
,
Hyaluronidase
,
Hyaluronidase
💬
| - | - | 1件: 28 28 💬
|
267 | Pegylated Somatropin | 1件: Somatotropin Somatotropin | - | - | - | 1件: 78 78 💬
|
268 | Pelubiprofen | 1件: Pelubiprofen Pelubiprofen | 1件: Pelubiprofen
Pelubiprofen
💬
| - | - | 1件: 46 46 💬
|
269 | Pelubiprofen 30 mg | 1件: Pelubiprofen Pelubiprofen | 1件: Pelubiprofen
Pelubiprofen
💬
| - | - | 1件: 46 46 💬
|
270 | Pemafibrate | 1件: Pemafibrate Pemafibrate | 1件: Pemafibrate
Pemafibrate
💬
| 1件: PPARA PPARA 💬
| 10件: Adipocytokine signaling pathway Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 | 1件: 93 93 💬
|
271 | Pembrolizumab | 1件: Pembrolizumab Pembrolizumab | 1件: Pembrolizumab
Pembrolizumab
💬
| 1件: PDCD1 PDCD1 💬
| 3件: Cell adhesion molecules Cell adhesion molecules, PD-L1 expression and PD-1 checkpoint pathway in cancer, T cell receptor signaling pathway 💬 | 2件: 25 25, 285 💬
|
272 | PEMINE - 150 MG CAPSULE RIGIDE 50 CAPSULE | - | - | - | - | 1件: 171 171 💬
|
273 | PEMIROLAST | 1件: Pemirolast Pemirolast | 1件: Pemirolast
Pemirolast
💬
| - | - | 1件: 113 113 💬
|
274 | Pemziviptadil (PB1046) Injection | - | - | - | - | 1件: 86 86 💬
|
275 | PEN+usual care | - | - | - | - | 1件: 96 96 💬
|
276 | Pending | - | - | - | - | 6件: 13 13, 19, 96, 97, 113, 302 💬
|
277 | Penicillamine | 1件: Penicillamine Penicillamine | 1件: Penicillamine
Penicillamine
💬
| - | - | 2件: 51 51, 171 💬
|
278 | Pentamidina | 1件: Pentamidine Pentamidine | 1件: Pentamidine
Pentamidine
💬
| - | - | 1件: 61 61 💬
|
279 | PENTAMIDINA ISETIONATO | 1件: Pentamidine Pentamidine | 1件: Pentamidine
Pentamidine
💬
| - | - | 1件: 61 61 💬
|
280 | Pentamidine | 1件: Pentamidine Pentamidine | 1件: Pentamidine
Pentamidine
💬
| - | - | 2件: 61 61, 65 💬
|
281 | Pentasa | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 2件: 96 96, 97 💬
|
282 | Pentasa 2g sachet prolonged release granules (95%) | 2件: Manganese citrate Manganese citrate, Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 1件: 97 97 💬
|
283 | Pentasa 500 mg Retardtabletten | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 1件: 97 97 💬
|
284 | Pentasa Compact 2g, granulate with prolonged release | 2件: Manganese citrate Manganese citrate, Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 1件: 97 97 💬
|
285 | Pentasa Compact 4g, granulate with prolonged release | 2件: Manganese citrate Manganese citrate, Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 1件: 97 97 💬
|
286 | Pentasa enema | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 1件: 97 97 💬
|
287 | Pentasa prolonged release granules 2g | 2件: Manganese citrate Manganese citrate, Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 1件: 97 97 💬
|
288 | PENTASA Sachet | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 2件: 96 96, 97 💬
|
289 | Pentasa Sachet 1 g | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 2件: 96 96, 97 💬
|
290 | Pentasa Sachet 1 g prolonged release granules | 2件: Manganese citrate Manganese citrate, Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 1件: 96 96 💬
|
291 | Pentasa Sachet 1g | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 1件: 97 97 💬
|
292 | Pentasa Sachet 2 g | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 1件: 97 97 💬
|
293 | Pentetreotide | 1件: Pentetreotide Pentetreotide | 1件: Pentetreotide
Pentetreotide
💬
| - | - | 1件: 75 75 💬
|
294 | Pentosan Polysulfat SP 54® injection solution | - | - | - | - | 1件: 19 19 💬
|
295 | Pentosan polysulfate | 1件: Pentosan polysulfate Pentosan polysulfate | - | - | - | 3件: 19 19, 26, 226 💬
|
296 | PENTOSAN POLYSULFATE SODIUM | 1件: Pentosan polysulfate Pentosan polysulfate | - | - | - | 1件: 19 19 💬
|
297 | Pentosan polysulfate sodium 100 mg | 1件: Pentosan polysulfate Pentosan polysulfate | - | - | - | 1件: 226 226 💬
|
298 | Pentosan Polysulphate SP54 | - | - | - | - | 1件: 19 19 💬
|
299 | Pentosan Polysulphate SP54® | - | - | - | - | 1件: 19 19 💬
|
300 | Pentoxifylline | 1件: Pentoxifylline Pentoxifylline | 1件: Pentoxifylline
Pentoxifylline
💬
| - | - | 12件: 26 26, 56, 84, 86, 93, 96, 97, 113, 220, 222, 296, 298 💬
|
301 | Pentoxifylline 400 MG | 1件: Pentoxifylline Pentoxifylline | 1件: Pentoxifylline
Pentoxifylline
💬
| - | - | 1件: 97 97 💬
|
302 | Peptide-conjugated phosphorodiamidate morpholino oligomer for exon 51 skipping | - | - | - | - | 1件: 113 113 💬
|
303 | Peptidic+Probiotic | - | - | - | - | 1件: 96 96 💬
|
304 | Perampanel | 1件: Perampanel Perampanel | 1件: Perampanel
Perampanel
💬
| 4件: GRIA1 GRIA1, GRIA2, GRIA3, GRIA4 💬
| 16件: Amphetamine addiction Amphetamine addiction, Amyotrophic lateral sclerosis, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Transcriptional misregulation in cancer, cAMP signaling pathway 💬 | 3件: 2 2, 6, 144 💬
|
305 | Percutaneous sirolimus | 1件: Sirolimus Sirolimus | 1件: Sirolimus
Sirolimus
💬
| 1件: MTOR MTOR 💬
| 51件: AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | 1件: 278 278 💬
|
306 | Perdix | - | - | - | - | 1件: 19 19 💬
|
307 | Peresolimab | - | - | - | - | 1件: 46 46 💬
|
308 | PERFALGAN | - | - | - | - | 1件: 2 2 💬
|
309 | Perflubutane | 1件: Perflubutane Perflubutane | 1件: Perflubutane
Perflubutane
💬
| - | - | 2件: 298 298, 300 💬
|
310 | Perfluorinated gas/oxygen mixture | 1件: Oxygen Oxygen | 1件: Oxygen
Oxygen
💬
| - | - | 1件: 299 299 💬
|
311 | Perform blood cells and fibroblasts biochemical and immuno-labeled investigations | - | - | - | - | 1件: 265 265 💬
|
312 | Perfusion of treatment Ocrelizumab | 1件: Ocrelizumab Ocrelizumab | 1件: Ocrelizumab
Ocrelizumab
💬
| 1件: MS4A1 MS4A1 💬
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 💬
|
313 | Perfusion of treatment Rituximab | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
💬
| 1件: MS4A1 MS4A1 💬
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 💬
|
314 | PERGOLIDE | 1件: Pergolide Pergolide | 1件: Pergolide
Pergolide
💬
| 2件: DRD1 DRD1, DRD2 💬
| 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
315 | Perhexiline | 1件: Perhexiline Perhexiline | 1件: Perhexiline
Perhexiline
💬
| 8件: CACNA1C CACNA1C, CACNA1D, CACNA1F, CACNA1S, CPT1A, CPT1B, CPT1C, CPT2 💬
| 47件: AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Adrenergic signaling in cardiomyocytes, Alcoholic liver disease, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Dilated cardiomyopathy, Dopaminergic synapse, Fatty acid degradation, Fatty acid metabolism, GABAergic synapse, Glucagon signaling pathway, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin resistance, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, PPAR signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Thermogenesis, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 2件: 58 58, 272 💬
|
316 | Peri-neural Dexamethasone 1 mg | 1件: Dexamethasone Dexamethasone | 1件: Dexamethasone
Dexamethasone
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 46 46 💬
|
317 | Perindopril | 1件: Perindopril Perindopril | 1件: Perindopril
Perindopril
💬
| 1件: ACE ACE 💬
| 6件: Chagas disease Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬 | 4件: 58 58, 113, 167, 222 💬
|
318 | Perindopril 2mg Tablets | 1件: Perindopril Perindopril | 1件: Perindopril
Perindopril
💬
| 1件: ACE ACE 💬
| 6件: Chagas disease Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬 | 1件: 113 113 💬
|
319 | PERINDOPRIL ARGININA | 2件: Arginine Arginine, Perindopril | 2件: Arginine
Arginine
,
Perindopril
💬
| 1件: ACE ACE 💬
| 6件: Chagas disease Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬 | 1件: 58 58 💬
|
320 | Perindopril arginine | 2件: Arginine Arginine, Perindopril | 2件: Arginine
Arginine
,
Perindopril
💬
| 1件: ACE ACE 💬
| 6件: Chagas disease Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬 | 1件: 58 58 💬
|
321 | Peripheral blood stem cell | - | - | - | - | 1件: 285 285 💬
|
322 | Peripheral Blood Stem Cells | - | - | - | - | 2件: 51 51, 65 💬
|
323 | Permitted DMARDs | - | - | - | - | 1件: 46 46 💬 |